Montag A & Associates Inc Cassava Sciences Inc Call Options Transaction History
Montag A & Associates Inc
- $2.09 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SAVA
# of Institutions
200Shares Held
13.7MCall Options Held
1.57MPut Options Held
3.86M-
Black Rock Inc. New York, NY3.22MShares$81.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.52MShares$63.5 Million0.0% of portfolio
-
State Street Corp Boston, MA1.16MShares$29.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.01MShares$25.4 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA691KShares$17.4 Million0.0% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $1.01B
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...